Ocean Capital CEO Discusses Enzyme Innovation, Biotechnology & Global Growth

Jun 17, 2026

At the New York Stock Exchange, Ocean Capital Founder and CEO Dr. Shuyu Zhou discusses the company’s vision of transforming scientific discoveries into real-world health and wellness solutions. From enzyme-based technologies to customized biotechnology platforms, Ocean Capital is focused on developing innovative products designed to improve human health, longevity, and quality of life.

Dr. Zhou explains how the company’s ecosystem spans research, product development, manufacturing, and commercialization, enabling tailored solutions across multiple markets. By leveraging enzyme science to support immune system function and overall wellness, Ocean Capital aims to bring cutting-edge biotechnology innovations from the laboratory to consumers around the world.

#OceanCapital
#Biotechnology
#EnzymeTechnology
#HealthInnovation
#Biotech
#Healthcare
#Wellness
#LifeSciences
#ImmuneHealth
#ScientificInnovation
#NYSE
#NewToTheStreet
#MonicaMalpass
#Innovation
#NewsOut